NEUROPACE, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.02 USD | +0.50% |
|
-6.82% | -23.08% |
| May. 13 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
| May. 08 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
a957070d424f64f29f8618.9elJP9su2lt7fNOUSZIfuoBbeZHAr5r8UAfRrczMGH4.zZgwR6sesxUpTYzlC_ws1rYwMOas7N6xCF2z1aiiTCnHpCJYlx22L05PvA~40a12b14d37cf57c11ada85b43cd72d9
